TaiGen Biopharmaceuticals Holdings Limited (TPEX:4157)
Taiwan
· Delayed Price · Currency is TWD 9.41
-0.04 (-0.42%)
Apr 24, 2025, 1:30 PM CST
TPEX:4157 Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 74.14 | 374.66 | 243.11 | 364.93 | 60.85 | Upgrade
|
| Short-Term Investments | 751.28 | 598.2 | 591.11 | 495.38 | 197.22 | Upgrade
|
| Trading Asset Securities | 194.4 | 65.14 | 64.39 | 64.09 | 72.7 | Upgrade
|
| Cash & Short-Term Investments | 1,020 | 1,038 | 898.6 | 924.4 | 330.78 | Upgrade
|
| Cash Growth | -1.75% | 15.51% | -2.79% | 179.46% | -48.12% | Upgrade
|
| Accounts Receivable | 7.33 | 8.98 | 18.41 | 278.28 | 7.31 | Upgrade
|
| Other Receivables | 9.07 | 24.88 | 5.3 | 2.61 | 28.64 | Upgrade
|
| Receivables | 16.4 | 33.87 | 23.71 | 280.89 | 35.95 | Upgrade
|
| Inventory | 42.71 | 34.15 | 15.35 | 17.88 | 14.65 | Upgrade
|
| Other Current Assets | 7.16 | 4.37 | 11.57 | 8.84 | 10.22 | Upgrade
|
| Total Current Assets | 1,086 | 1,110 | 949.24 | 1,232 | 391.6 | Upgrade
|
| Property, Plant & Equipment | 67.47 | 90.61 | 56.6 | 80.43 | 42.47 | Upgrade
|
| Long-Term Investments | 2.45 | 9.71 | 23.98 | 53.9 | 85.86 | Upgrade
|
| Other Intangible Assets | 12.05 | 12.99 | 0.23 | 0.16 | 0.29 | Upgrade
|
| Other Long-Term Assets | 6.22 | 6.16 | 16.96 | 26.31 | 36.24 | Upgrade
|
| Total Assets | 1,174 | 1,230 | 1,047 | 1,393 | 556.45 | Upgrade
|
| Short-Term Debt | - | - | 3 | - | - | Upgrade
|
| Current Portion of Leases | 16.33 | 15.98 | 18.34 | 17.99 | 17.12 | Upgrade
|
| Current Income Taxes Payable | 0.11 | - | 3.07 | 27.86 | - | Upgrade
|
| Current Unearned Revenue | 0.15 | 0.15 | 0.15 | 0.18 | 44.41 | Upgrade
|
| Other Current Liabilities | 29.5 | 31.76 | 26.76 | 43.85 | 33.37 | Upgrade
|
| Total Current Liabilities | 46.08 | 47.89 | 51.32 | 89.88 | 94.91 | Upgrade
|
| Long-Term Leases | 42.39 | 58.71 | 17.13 | 35.47 | - | Upgrade
|
| Long-Term Unearned Revenue | 0.18 | 0.33 | 0.48 | 0.62 | 0.79 | Upgrade
|
| Total Liabilities | 91.96 | 110.94 | 76.98 | 139.11 | 114.26 | Upgrade
|
| Common Stock | 20.94 | 20.94 | 20.91 | 20.91 | 20.91 | Upgrade
|
| Additional Paid-In Capital | 466.3 | 444.61 | 450.26 | 455.25 | 675.14 | Upgrade
|
| Retained Earnings | 640.6 | 678.68 | 542.05 | 778.3 | -300.21 | Upgrade
|
| Comprehensive Income & Other | -45.51 | -25.34 | -43.2 | -0.77 | 46.34 | Upgrade
|
| Shareholders' Equity | 1,082 | 1,119 | 970.03 | 1,254 | 442.18 | Upgrade
|
| Total Liabilities & Equity | 1,174 | 1,230 | 1,047 | 1,393 | 556.45 | Upgrade
|
| Total Debt | 58.71 | 74.69 | 38.47 | 53.46 | 17.12 | Upgrade
|
| Net Cash (Debt) | 961.11 | 963.3 | 860.13 | 870.94 | 313.66 | Upgrade
|
| Net Cash Growth | -0.23% | 12.00% | -1.24% | 177.67% | -45.10% | Upgrade
|
| Net Cash Per Share | 1.34 | 1.34 | 1.20 | 1.21 | 0.44 | Upgrade
|
| Filing Date Shares Outstanding | 717.84 | 717.84 | 716.84 | 716.84 | 716.84 | Upgrade
|
| Total Common Shares Outstanding | 717.84 | 717.84 | 716.84 | 716.84 | 716.84 | Upgrade
|
| Working Capital | 1,040 | 1,062 | 897.92 | 1,142 | 296.69 | Upgrade
|
| Book Value Per Share | 1.51 | 1.56 | 1.35 | 1.75 | 0.62 | Upgrade
|
| Tangible Book Value | 1,070 | 1,106 | 969.8 | 1,254 | 441.89 | Upgrade
|
| Tangible Book Value Per Share | 1.49 | 1.54 | 1.35 | 1.75 | 0.62 | Upgrade
|
| Machinery | 144.93 | 144.38 | 143.76 | 140.92 | 148.2 | Upgrade
|
| Leasehold Improvements | 60.79 | 60.66 | 60.71 | 60.67 | 58.11 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.